Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - BWCG


VANCOUVER, BC, Oct. 30, 2023 /CNW/ - Trading resumes in:

Company: Blackwolf Copper and Gold Ltd.

TSX-Venture Symbol: BWCG

All Issues: Yes

Resumption (ET): 10:00 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 23:00
TerraPay, a leading global money movement company, has joined forces with Multipass, a bank challenger in the financial technology sector, to redefine cross-border payment solutions for corporate customers. This strategic collaboration aims to offer...

at 22:38
BSM Partners, the largest full-service pet care research, consulting, and strategy-to-shelf product innovation firm, announced the expansion of its global footprint with the opening of the firm's first European office....

at 22:35
On May 6, 2024, the Board of Directors (the "Board") of Truett-Hurst, Inc. (the "Company") set May 16, 2024 as the record date (the "Record Date") for the determination of the shareholders of the Company entitled to receive distributions upon the...

at 22:35
Jacob Warnock (the "Acquiror") is pleased to announce that, on May 3, 2024, he indirectly acquired (the "Acquisition") control and/or direction over an aggregate of 7,924,157 units ("Units") of International Battery Metals Ltd. (the "Issuer"), a...

at 22:30
Information Mediary Corp (IMC) and Adherence have collaborated to introduce a digitized Morisky Medication Adherence Scale (MMAS), revolutionizing medication adherence management. This innovative solution signifies a significant advancement in...

at 22:15
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of a public offering of 804,999 shares...



News published on and distributed by: